584 filings
Page 21 of 30
8-K/A
nrc6mdi0
13 Apr 10
Financial Statements and Exhibits
12:00am
424B4
lrowjylw2xuzwa2u di
8 Apr 10
Prospectus supplement with pricing info
12:00am
8-K
pvrd0 x5t9w35
8 Apr 10
Entry into a Material Definitive Agreement
12:00am
8-K
rjcu0olib 6g
30 Mar 10
Departure of Directors or Certain Officers
12:00am
8-K
260nruha18l2ndpjps30
23 Mar 10
Pharmathene Reports Year-end 2009 Financial and Operational Results and Provides Update on Ongoing Litigation with Siga Technologies
12:00am
8-K
2kret0sk
22 Mar 10
Regulation FD Disclosure
12:00am
UPLOAD
a6z0nl12z0rgj
1 Mar 10
Letter from SEC
12:00am
8-K
sjmcng
26 Feb 10
Pharmathene Awarded Up to Additional $78.4 Million Under Existing
12:00am
CORRESP
1ss8xvj
26 Feb 10
Correspondence with SEC
12:00am
CORRESP
zf4z 914szadkl
18 Feb 10
Correspondence with SEC
12:00am
UPLOAD
g7r6 6e0z
4 Feb 10
Letter from SEC
12:00am
CT ORDER
jzwq 25vw8un
25 Jan 10
Confidential treatment order
12:00am
CORRESP
6e2e jg22ewsx2q2ypm3
22 Jan 10
Correspondence with SEC
12:00am
CORRESP
lm1qc oiut1dvyn9c3pj
5 Jan 10
Correspondence with SEC
12:00am
8-K
ci9mrksoihnk 865
23 Dec 09
Departure of Directors or Certain Officers
12:00am
UPLOAD
v8xv0i8wlu
22 Dec 09
Letter from SEC
12:00am
8-K
m8zg d3ydpsfh4iku
9 Dec 09
PIP - Pharmathene Conference Call to provide an update on its rPA program
12:00am
8-K
gea5eb
8 Dec 09
Barda Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines
12:00am